{rfName}
Ca

Indexed in

License and use

Altmetrics

Analysis of institutional authors

Mari Ayala, MartaAuthorFernandez Vidal, AndreaAuthorBosch, MAuthorMari, MAuthorHerms, AAuthorFajardo, AAuthorGiralt, AAuthorColell, AAuthorGonzalez-Moreno, EAuthorMatias, NAuthorTebar, FAuthorEnrich, CAuthorGarcia-Ruiz, CAuthorPerez-Navarro, EAuthorFernandez-Checa, JcCorresponding AuthorPol, AAuthor

Share

May 5, 2014
Publications
>
Article
No

Caveolin-1 Deficiency Causes Cholesterol-Dependent Mitochondrial Dysfunction and Apoptotic Susceptibility

Publicated to:Current Biology. 21 (8): 681-686 - 2011-04-26 21(8), DOI: 10.1016/j.cub.2011.03.030

Authors: Bosch, Marta; Mari, Montserrat; Herms, Albert; Fernandez, Ana; Fajardo, Alba; Kassan, Adam; Giralt, Albert; Colell, Anna; Balgoma, David; Barbero, Elisabet; Gonzalez-Moreno, Elena; Matias, Nuria; Tebar, Francesc; Balsinde, Jesus; Camps, Marta; Enrich, Carlos; Gross, Steven P; Garcia-Ruiz, Carmen; Perez-Navarro, Esther; Fernandez-Checa, Jose C; Pol, Albert

Affiliations

C1BER Diabet & Enfermedades Metab Asociadas, Barcelona 08036, Spain - Author
CSIC, IDIBAPS, Dept Mort Cel Lular & Proliferacio, Barcelona 08036, Spain - Author
CSIC, Inst Biol & Genet Mol, Valladolid 47003, Spain - Author
Hosp Clin Barcelona, Unitat Hepatol, Ctr Invest Biomed Esther Koplowitz, Barcelona 08036, Spain - Author
IDIBAPS, Fac Med, Dept Biol Cel Lular Immunol & Neurociencies, Barcelona 08036, Spain - Author
Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain - Author
Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona 08036, Spain - Author
Inst Recerca Biomed Barcelona, Barcelona 08028, Spain - Author
Institut d'Investigacions Biomèdiques August Pi i Sunyer - IDIBAPS - Author
Univ Barcelona, Ctr Invest Biomed Red CIBER Enfermedades Neurodeg, E-08036 Barcelona, Spain - Author
Univ Barcelona, Dept Bioquim & Biol Mol, E-08028 Barcelona, Spain - Author
Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA - Author
Univ So Calif, Keck Sch Med, Res Ctr Alcohol Liver & Pancreat Dis, Los Angeles, CA 90033 USA - Author
See more

Abstract

Caveolins (CAVs) are essential components of caveolae, plasma membrane invaginations with reduced fluidity, reflecting cholesterol accumulation. CAV proteins bind cholesterol, and CAV's ability to move between cellular compartments helps control intracellular cholesterol fluxes. In humans, CAV1 mutations result in lipodystrophy, cell transformation, and cancer. CAV1 gene-disrupted mice exhibit cardiovascular diseases, diabetes, cancer, atherosclerosis, and pulmonary fibrosis. The mechanism or mechanisms underlying these disparate effects are unknown, but our past work suggested that CAV1 deficiency might alter metabolism: CAV1(-/-) mice exhibit impaired liver regeneration unless supplemented with glucose, suggesting systemic inefficiencies requiring additional metabolic intermediates. Establishing a functional link between CAV1 and metabolism would provide a unifying theme to explain these myriad pathologies. Here we demonstrate that impaired proliferation and low survival with glucose restriction is a shortcoming of CAV1-deficient cells caused by impaired mitochondrial function. Without CAV1, free cholesterol accumulates in mitochondrial membranes, increasing membrane condensation and reducing efficiency of the respiratory chain and intrinsic antioxidant defense. Upon activation of oxidative phosphorylation, this promotes accumulation of reactive oxygen species, resulting in cell death. We confirm that this mitochondrial dysfunction predisposes CAV1-deficient animals to mitochondrial-related diseases such as steatohepatitis and neurodegeneration.Copyright © 2011 Elsevier Ltd. All rights reserved.

Keywords

cancermechanismsstresstraffickingAnimalsApoptosisCancerCaveolin 1Cell proliferationCholesterolDiseaseFibroblastsGlucoseMechanismsMiceMitochondriaMitochondrial membranesNull micePhosphorylationStress

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Current Biology due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2011, it was in position 18/290, thus managing to position itself as a Q1 (Primer Cuartil), in the category Biochemistry & Molecular Biology.

From a relative perspective, and based on the normalized impact indicator calculated from the Field Citation Ratio (FCR) of the Dimensions source, it yields a value of: 14.15, which indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: Dimensions Jul 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-07-06, the following number of citations:

  • WoS: 170
  • Scopus: 136
  • Europe PMC: 123
  • Google Scholar: 238

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-07-06:

  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 176 (PlumX).

Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: CAMBRIDGE; United States of America.

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: First Author (Bosch Rodriguez, Marta) and Last Author (Pol Sorolla, Albert).

the author responsible for correspondence tasks has been Fernández-Checa Torres, José Carlos.